Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy

Circulation: Cardiovascular Imaging · Published 2026-07-23 · DOI 10.1161/circimaging.126.019832

Free full text

Authors (24)

Gregorio Tersalvi, Melanie C. Bois, Christopher G. Scott, Patricia Carey, Armin Garmany, Daniel R. Davies, Andrew C. Hoffman, Jun Zhang, Carrie B. Hruska, Hayan Jouni, Martin G. Rodriguez-Porcel, J. Wells Askew, John P. Bois, Kathleen A. Young, Nandan S. Anavekar, Ian C. Chang, Martha Grogan, Angela Dispenzieri, Joseph J. Maleszewski, Andrew C. Homb, Margaret M. Redfield, Panithaya Chareonthaitawee, Geoffrey B. Johnson, Omar F. AbouEzzeddine

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tersalvi, G., Bois, M., Scott, C., et al. (2026). Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.126.019832

Related articles